CTLA4 Polymorphisms and De Novo Malignancy Risk after Renal Transplantation in Chinese Recipients

Table 2

Multiplicative interaction between possible risk factors of malignancy.

Variables^*	Age	Sex	Primary diseases	Dialysis time (≥3 years)	Number of HLA-mismatch	Antibody induction therapy
Sex	0.994	—	—	—	—	—
Primary diseases	0.053	0.766	—	—	—	—
Dialysis time (≥3 years)	0.612	0.560	0.043	—	—	—
Number of HLA-mismatch	0.966	0.886	0.815	0.055	—	—
Antibody induction therapy	0.001	0.838	0.002	0.275	0.281	—
Rejection	0.080	0.590	0.094	0.057	0.981	0.282

The figures in the table were value.